A novel tool known as the Florey Dementia Index (FDI) predicted onset age of mild cognitive impairment or Alzheimer's disease ...
According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...
DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment ...
Neurologists hope this tongue-in-cheek study will spark serious conversations about AI's limitations and the benefits of a ...